Summary & Overview
HCPCS G0124: Cervical/Vaginal Screening Cytopathology, Thin-Layer
HCPCS Level II code G0124 covers physician-interpreted screening cytopathology of the cervix or vagina when specimens are collected in preservative fluid and processed with an automated thin-layer preparation. Nationally, this code is part of routine cervical cancer screening workflows and laboratory billing for gynecologic cytology. It matters because screening modality and preparation method can affect laboratory workflows, coding specificity, and payer coverage policies.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, and the clinical context for automated thin-layer cytology screening. The publication summarizes common billing considerations, frequently used modifiers (listed separately), and how G0124 relates to laboratory service lines.
The report provides national benchmarks where available, notes relevant policy and coverage themes affecting screening cytology, and clarifies clinical context for use of automated thin-layer preparations. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G0124 describes screening cytopathology of the cervix or vagina collected in preservative fluid and prepared using an automated thin layer preparation method. The service requires interpretation by a physician and is intended for cytologic screening rather than diagnostic or therapeutic procedures.
-
Service type: Laboratory screening cytopathology using automated thin-layer preparation
-
Typical site of service: Clinical laboratory or outpatient laboratory facility
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman presents to a primary care clinic for routine cervical cancer screening. A clinician performs a pelvic exam and collects a cervical cytology specimen using a broom or brush device and places the cellular sample into a preservative fluid vial for an automated thin-layer preparation (liquid-based cytology). The specimen is sent to the pathology laboratory where a cytotechnologist prepares the thin-layer slide using an automated processor and forwards the slide to a pathologist for microscopic interpretation. The pathologist reviews the cellular morphology, reports results using the chosen reporting system (e.g., Bethesda), and issues a screening cytopathology report to the ordering provider. This service corresponds to screening cytopathology of the cervix or vagina collected in preservative fluid with automated thin-layer preparation requiring physician interpretation billed with G0124.
Common workflow steps:
-
Patient check-in, consent, and indication for screening
-
Specimen collection into preservative fluid at clinic
-
Specimen accessioning and automated thin-layer slide preparation in lab
-
Microscopic interpretation and final report by pathologist
-
Results communicated to ordering clinician and patient for follow-up as needed
Coding Specifications
| Modifier |
|---|